Table 1 Association between AGK expression and the clinicopathological features of RCC
Feature | No. of patients | AGK expression | P-value | |
|---|---|---|---|---|
Low | High | |||
Gender | ||||
Male | 81 (67.5%) | 41 (50.6%) | 40 (49.4%) | 1.000 |
Female | 39 (32.5%) | 19 (48.7%) | 20 (51.3%) | |
Age(years) | ||||
< 50 | 68 (56.7%) | 32 (47.1%) | 36 (52.9%) | 0.581 |
≥ 50 | 52 (43.3%) | 28 (53.8%) | 24 (46.2%) | |
Family history of cancer | ||||
Yes | 10 (8.3%) | 4 (40.0%) | 6 (60.0%) | 0.743 |
No | 110 (91.7%) | 56 (50.9%) | 54 (49.1%) | |
Clinical stage | ||||
I-II | 83 (69.2%) | 51 (61.4%) | 32 (38.6%) | < 0.001 |
III-IV | 37 (30.8%) | 9 (24.3%) | 28 (75.7%) | |
Pathological classification | ||||
Renal clear cell carcinoma | 116 (96.7%) | 57 (49.1%) | 59 (50.9%) | 0.619 |
Others | 4 (3.3%) | 3 (75.0%) | 1 (25.0%) | |
Fuhrman classification | ||||
I-II | 96 (80.0%) | 54 (56.3%) | 42 (43.7%) | 0.011 |
III-IV | 24 (20.0%) | 6 (25.0%) | 18 (75.0%) | |
Recurrence with metastasis | ||||
Absent | 93 (77.5%) | 57 (61.3%) | 36 (38.7%) | < 0.001 |
Present | 27 (22.5%) | 8 (11.1%) | 19 (88.9%) | |
Vital status | ||||
Alive | 97 (80.8%) | 58 (59.8%) | 39 (40.2%) | < 0.001 |
Dead | 23 (19.2%) | 2 (8.7%) | 21 (91.3%) | |